首页> 外文期刊>International Journal of Research in Medical Sciences >Microalbuminuria as an overrated indicator of target organ damage in hypertension: a hospital based cross sectional study
【24h】

Microalbuminuria as an overrated indicator of target organ damage in hypertension: a hospital based cross sectional study

机译:微蛋白尿作为高血压靶器官损伤的高估指标:基于医院的横断面研究

获取原文
           

摘要

Background: Hypertension is one of the leading causes of global burden of disease. Uncontrolled hypertension is associated with long term risk of damage to vital organs like brain, heart, kidney, blood vessels and eye i.e. Target Organ Damage (TOD). Medical scientists all over the world have been in search for an indicator which can accurately predict TOD. It is accepted that Microalbuminuria (MA) represents a more generalised vascular problem, not only confined to renal microcirculation. MA is found in a significant proportion of non-diabetic population, particularly in association with hypertension and is a predictor of cardiovascular disease. The objective of the study was to evaluate MA in hypertension and its correlation with TOD. Methods: A Hospital based cross sectional study carried out in the department medicine of central referral hospital, a well-equipped tertiary care hospital in East Sikkim, Gangtok. 200 patients were recruited fulfilling the inclusion criteria of pre hypertension, stage 1 & 2 hypertension as defined by JNC 7 report. Patients with secondary hypertension, DM, ESRD & hyperuricemia were excluded. MA was estimated by Immunoturbidimetry. Results: MA is associated with all TOD but significant correlation was found only with retinopathy. Out of 200 study subjects, 90 (45%) subjects had retinopathy out of which 54 (60%) had MA and 36 (40%) did not have MA. (P Conclusion: MA has established its position in DM where it indicates early end organ damage and heralds cardiovascular risk. Its role as a reliable indicator of TOD in non-diabetic hypertensives needs further evaluation.
机译:背景:高血压是全球疾病负担的主要原因之一。不受控制的高血压与大脑,心脏,肾脏,血管和眼睛等重要器官损伤的长期风险有关,目标器官损失(TOD)。世界各地的医学科学家一直在寻找能够准确预测TOD的指标。可接受的是微量白蛋白尿(MA)代表更广泛的血管问题,不仅限于肾微循环。 MA在很大程度上存在于非糖尿病群,特别是与高血压相关,并且是心血管疾病的预测因素。该研究的目的是评估高血压的MA及其与TOD的相关性。方法:在Central Evercal医院部门医学中进行了一项基于医院的横截面研究,该医院在东锡克基姆的装备精良的高等教育医院,甘塔克。招募了200名患者,满足了JNC 7报告所定义的预高血压,1级和2个高血压的纳入标准。患有继发性高血压,DM,ESRD和Heaturecemia的患者被排除在外。 MA由免疫浊法估计。结果:MA与所有TOD相关,但仅发现具有视网膜病变的显着相关性。在200个研究受试者中,90例(45%)受试者有视网膜病变,其中54(60%)有MA,36(40%)没有MA。 (P结论:MA在DM中建立了它的位置,其中它表明早期器官损害和预示着心血管风险。其作为非糖尿病高压剂中TOD的可靠指标的作用需要进一步评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号